Global Nizatidine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nizatidine Market Research Report 2024
Nizatidine is a gastric acid secretion inhibitor developed by Lilai Company in the United States. It was first marketed in the United States in 1987 and its name is Axid. Nizatidine is a potent H2 receptor antagonist. It acts on gastric acid secreting cells, blocking the formation of gastric acid and reducing basic gastric acid. It also inhibits gastric acid secretion caused by food and chemical stimulation, such as gastrin and acetylcholine. The action intensity is similar to ranitidine and better than cimetidine.
According to Mr Accuracy reports’s new survey, global Nizatidine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nizatidine market research.
Key manufacturers engaged in the Nizatidine industry include Flynn Pharma, MedChemExpress, Mylan, Glenmark, Weightech(Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy's Laboratories, Lilly and Strides Pharma Science, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nizatidine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nizatidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nizatidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Flynn Pharma
MedChemExpress
Mylan
Glenmark
Weightech(Hunan) Pharmaceutical
Hengdian Group
Dr. Reddy's Laboratories
Lilly
Strides Pharma Science
Chongqing Zhien Pharmaceutical
Changzhou Sailu Industry
Segment by Type
Capsule
Tablets
Other
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Nizatidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Nizatidine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nizatidine market research.
Key manufacturers engaged in the Nizatidine industry include Flynn Pharma, MedChemExpress, Mylan, Glenmark, Weightech(Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy's Laboratories, Lilly and Strides Pharma Science, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nizatidine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nizatidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nizatidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Flynn Pharma
MedChemExpress
Mylan
Glenmark
Weightech(Hunan) Pharmaceutical
Hengdian Group
Dr. Reddy's Laboratories
Lilly
Strides Pharma Science
Chongqing Zhien Pharmaceutical
Changzhou Sailu Industry
Segment by Type
Capsule
Tablets
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Nizatidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices